Cargando…

(68)Ga-TRAP-(RGD)(3) Hybrid Imaging for the In Vivo Monitoring of α(v)ß(3)-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer

OBJECTIVES: To investigate (68)Ga-TRAP-(RGD)(3) hybrid imaging for the in vivo monitoring of α(v)ß(3)-integrin expression as biomarker of anti-angiogenic therapy effects in experimental breast cancer. MATERIALS AND METHODS: Human breast cancer (MDA-MB-231) xenografts were implanted orthotopically in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kazmierczak, Philipp M., Todica, Andrei, Gildehaus, Franz-Josef, Hirner-Eppeneder, Heidrun, Brendel, Matthias, Eschbach, Ralf S., Hellmann, Magdalena, Nikolaou, Konstantin, Reiser, Maximilian F., Wester, Hans-Jürgen, Kropf, Saskia, Rominger, Axel, Cyran, Clemens C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167276/ https://www.ncbi.nlm.nih.gov/pubmed/27992512 http://dx.doi.org/10.1371/journal.pone.0168248

Ejemplares similares

Monitoring Cell Death in Regorafenib-Treated Experimental Colon Carcinomas Using Annexin-Based Optical Fluorescence Imaging Validated by Perfusion MRI
por: Kazmierczak, Philipp M., et al.
Publicado: (2015)

Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma
por: Kazmierczak, Philipp M., et al.
Publicado: (2018)

Monitoring Early Response to Anti-Angiogenic Therapy: Diffusion-Weighted Magnetic Resonance Imaging and Volume Measurements in Colon Carcinoma Xenografts
por: Schneider, Moritz Jörg, et al.
Publicado: (2014)

Correlation of Perfusion MRI and (18)F-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation
por: Eschbach, Ralf S., et al.
Publicado: (2015)

(18)F–FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma
por: Eschbach, Ralf S., et al.
Publicado: (2018)

Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation
por: Eschbach, Ralf Stefan, et al.
Publicado: (2017)

Regorafenib Effects on Human Colon Carcinoma Xenografts Monitored by Dynamic Contrast-Enhanced Computed Tomography with Immunohistochemical Validation
por: Cyran, Clemens C., et al.
Publicado: (2013)

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
por: Kunz, Wolfgang G., et al.
Publicado: (2018)

Feasibility of [(68)Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
por: Unterrainer, Lena M., et al.
Publicado: (2022)

(68)Ga-EMP-100 PET/CT—a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma—first in-human biodistribution and imaging results
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Comparison between (68)Ga-bombesin ((68)Ga-BZH3) and the cRGD tetramer (68)Ga-RGD(4 )studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line
por: Cheng, Caixia, et al.
Publicado: (2011)

Age determination of vessel wall hematoma in spontaneous cervical artery dissection: A multi-sequence 3T Cardiovascular Magnetic resonance study
por: Habs, Maximilian, et al.
Publicado: (2011)

The added diagnostic value of complementary gadoxetic acid-enhanced MRI to (18)F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma
por: Puhr-Westerheide, Daniel, et al.
Publicado: (2019)

Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD—In Vivo Imaging Studies in Human Xenograft Tumors
por: Zhai, Chuangyan, et al.
Publicado: (2016)

Erratum: Vol. 68, No. SS-8
Publicado: (2019)

Erratum: Vol. 68, No. SS-11
Publicado: (2020)

[(68)Ga]FSC-(RGD)(3) a trimeric RGD peptide for imaging α(v)β(3) integrin expression based on a novel siderophore derived chelating scaffold—synthesis and evaluation
por: Knetsch, Peter A., et al.
Publicado: (2015)

Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy
por: Stechele, Matthias, et al.
Publicado: (2023)

iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis
por: Egorova, Anna, et al.
Publicado: (2023)

(68)Ga-BBN-RGD PET/CT for GRPR and Integrin α(v)β(3) Imaging in Patients with Breast Cancer
por: Zhang, Jingjing, et al.
Publicado: (2018)

Evaluation of [(68)Ga]Ga-NODAGA-RGD for PET Imaging of Rat Autoimmune Myocarditis
por: Jahandideh, Arghavan, et al.
Publicado: (2021)

Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving (90)Y-radioembolization
por: Hirner-Eppeneder, Heidrun, et al.
Publicado: (2023)

PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides
por: Dijkgraaf, Ingrid, et al.
Publicado: (2010)

Imaging of α(v)β(3) integrin expression in experimental myocardial ischemia with [(68)Ga]NODAGA-RGD positron emission tomography
por: Grönman, Maria, et al.
Publicado: (2017)

Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients
por: van Genugten, Evelien A. J., et al.
Publicado: (2023)

Clinical Evaluation of (68)Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α(v)β(3) in Various Cancer Types
por: Zhao, Liang, et al.
Publicado: (2023)

Exploring the Role of RGD-Recognizing Integrins in Cancer
por: Nieberler, Markus, et al.
Publicado: (2017)

Human Dose Assessment of (68)Ga-NODAGA-RGD-BBN Heterodimer Peptide based on Animal Data
por: Amraee, Naeimeh, et al.
Publicado: (2022)

(68)Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells
por: Fanelli, Roberto, et al.
Publicado: (2014)

Non-Contrast-Enhanced MR Angiography at 3 Tesla in Patients with Advanced Peripheral Arterial Occlusive Disease
por: Thierfelder, Kolja M., et al.
Publicado: (2014)

Comparison of symptomatic and asymptomatic atherosclerotic carotid plaques using parallel imaging and 3 T black-blood in vivo CMR
por: Grimm, Jochen M, et al.
Publicado: (2013)

Comparison of cyclic RGD peptides for α(v)β(3) integrin detection in a rat model of myocardial infarction
por: Laitinen, Iina, et al.
Publicado: (2013)

[(68)Ga]NODAGA-RGD – Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis
por: Haubner, Roland, et al.
Publicado: (2016)

PET imaging of (68)Ga-NODAGA-RGD, as compared with (18)F-fluorodeoxyglucose, in experimental rodent models of engrafted glioblastoma
por: Isal, Sibel, et al.
Publicado: (2018)

Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [(68)Ga]Ga-FAPI-RGD
por: Zang, Jie, et al.
Publicado: (2022)

Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging
por: Tsoukalas, Charalmpos, et al.
Publicado: (2015)

Imaging angiogenesis in atherosclerosis in large arteries with (68)Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease
por: Dietz, Matthieu, et al.
Publicado: (2021)

Dual targeting PET tracer [(68)Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study
por: Wang, Rongxi, et al.
Publicado: (2023)

Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET
por: Notni, Johannes, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4ffmpavu8asi831rvs1d2594fu